PERSPECTA

News from every angle

Back to headlines

Novo Nordisk Cuts Ozempic and Wegovy Prices, Potentially Boosting Stock

Novo Nordisk is implementing price reductions for its popular drugs Ozempic and Wegovy, a strategic move that analysts suggest could ultimately benefit the company's stock performance.

9 Mar, 16:20 — 9 Mar, 16:20
PostShare

Sources

Showing 1 of 1 sources